Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Multiple Sclerosis

Free Subscription Articles published in Can J Neurol Sci Retrieve available abstracts of 18 articles: HTML format

Single Articles

January 2026
1. OZDEMIR O, Batuk IT, Fil Balkan A, Acar Ozen P, et al
   The Role of Central Vestibular Dysfunction in Cognitive and Physical Impairment in Ambulatory Multiple Sclerosis.
   Can J Neurol Sci. 2026 Jan 2:1-8. doi: 10.1017/cjn.2025.10502.
   PubMed     Abstract available
   
   
   December 2025
2. BHATELE P, Prabhu AN, Pai AR
   Impact of Autoantibody Status on Visual Outcomes in Severe Optic Neuritis Patients Without Multiple Sclerosis.
   Can J Neurol Sci. 2025 Dec 16:1-7. doi: 10.1017/cjn.2025.10474.
   PubMed     Abstract available
   
   
   November 2025
3. GLENNIE J, Strasser L, Ciftci B, Johnstone J, et al
   Equity of access to disease modifying therapy for pediatric multiple sclerosis: a survey of Canadian prescribers.
   Can J Neurol Sci. 2025 Nov 21:1-9. doi: 10.1017/cjn.2025.10479.
   PubMed    
   
   
   October 2025
4. BLAGUI S, Iorio-Morin C
   Reviewer Comment on Guillemette et al. "Outcomes of CyberKnife Radiosurgery for Trigeminal Neuralgia in Patients with Multiple Sclerosis".
   Can J Neurol Sci. 2025 Oct 3:1. doi: 10.1017/cjn.2025.
   PubMed    
   
   
   June 2025
5. FREEDMAN MS, Clift F, Devonshire V, Emond F, et al
   First-line use of higher-efficacy disease-modifying therapies in multiple sclerosis: Canadian consensus recommendations.
   Can J Neurol Sci. 2025 Jun 9:1-28. doi: 10.1017/cjn.2025.10342.
   PubMed    
   
   
   May 2025
6. FREEDMAN DE, Sundaram ANE, Oh J, Feinstein A, et al
   How does time of testing influence cognitive performance in multiple sclerosis?
   Can J Neurol Sci. 2025 May 19:1-7. doi: 10.1017/cjn.2025.10125.
   PubMed    
   
   
   March 2025
7. FIFIELD KE, Fudge NJ, Arsenault ST, Anthony S, et al
   An overview of multiple sclerosis care in rural and urban Newfoundland and Labrador.
   Can J Neurol Sci. 2025 Mar 12:1-25. doi: 10.1017/cjn.2025.
   PubMed    
   
   
   
8. NATHOO N, Clark WI, Robinson R, Jarvis S, et al
   Indigenous Peoples Living with Multiple Sclerosis in Canada.
   Can J Neurol Sci. 2025 Mar 4:1-14. doi: 10.1017/cjn.2025.
   PubMed    
   
   
   
9. GUILLEMETTE A, Roberge D, Menard C, Bahary JP, et al
   Outcomes of CyberKnife Radiosurgery for Trigeminal Neuralgia in Patients with Multiple Sclerosis.
   Can J Neurol Sci. 2025 Mar 3:1-22. doi: 10.1017/cjn.2025.
   PubMed    
   
   
   November 2024
10. SA'DI Q, Alsmadi S, Shtaiyat W, Qasaimeh M, et al
    FLVCR1 Gene Mutation in a Patient with an Atypical Multiple Sclerosis-Like Presentation.
    Can J Neurol Sci. 2024 Nov 27:1-12. doi: 10.1017/cjn.2024.
    PubMed    
    
    
    
11. GONCUOGLU C, Acar-Ozen P, Kasikci M, Tuncer A, et al
    Pharmacist-implemented self-management module in multiple sclerosis patients: A randomized controlled trial.
    Can J Neurol Sci. 2024 Nov 13:1-27. doi: 10.1017/cjn.2024.
    PubMed    
    
    
    October 2024
12. MCCOMBE JA, Smyth P, Kate M, So H, et al
    Healthcare Cost of Multiple Sclerosis and in Relation to Disability Level in Alberta.
    Can J Neurol Sci. 2024 Oct 2:1-12. doi: 10.1017/cjn.2024.
    PubMed     Abstract available
    
    
    May 2024
13. OH J, Bhan V, Traboulsee A, Morrow SA, et al
    Health Canada drug approval process: a barrier to personalized care in multiple sclerosis.
    Can J Neurol Sci. 2024 May 23:1-12. doi: 10.1017/cjn.2024.
    PubMed    
    
    
    April 2024
14. BALCOM EF, McCombe JA, Kate M, Vu K, et al
    Geographical variation in medication and health resource use in multiple sclerosis.
    Can J Neurol Sci. 2024 Apr 11:1-21. doi: 10.1017/cjn.2024.
    PubMed    
    
    
    February 2024
15. NOBILE S, Beauchemin P
    Hypogammaglobulinemia and Infection Risk in an Ocrelizumab-treated Multiple Sclerosis Cohort.
    Can J Neurol Sci. 2024 Feb 12:1-21. doi: 10.1017/cjn.2024.
    PubMed    
    
    
    November 2023
16. HANDZIC A, Margolin E
    Myelin Oligodendrocyte Glycoprotein-related isolated internuclear ophthalmoplegia mimicking multiple sclerosis.
    Can J Neurol Sci. 2023 Nov 7:1-5. doi: 10.1017/cjn.2023.
    PubMed    
    
    
    September 2023
17. DHAR D, Kamble N, Pal PK
    Long Latency Reflexes in Clinical Neurology: A Systematic Review.
    Can J Neurol Sci. 2023;50:751-763.
    PubMed     Abstract available
    
    
    April 2023
18. GIACOMINI PS, Oh J, Morrow SA, Beauchemin P, et al
    Virtual management of multiple sclerosis: providing access or just phoning it in?
    Can J Neurol Sci. 2023 Apr 17:1-11. doi: 10.1017/cjn.2023.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.